Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.1990-0.0090 (-4.33%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2080
Open0.2000
Bid0.1989 x 1100
Ask0.2245 x 1000
Day's Range0.1986 - 0.2285
52 Week Range0.1700 - 0.8800
Volume833,769
Avg. Volume423,017
Market Cap8.947M
Beta (5Y Monthly)3.40
PE Ratio (TTM)N/A
EPS (TTM)-0.1730
Earnings DateMar 23, 2022 - Mar 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.23
  • Business Wire

    NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

    EMERYVILLE, Calif., May 12, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2022 and provides a business update. Financial results for the first quarter of 2022 include the operations of the DERMAdoctor business, which was acquired on November 5, 2021.

  • Business Wire

    NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations

    EMERYVILLE, Calif., May 09, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the expansion of its top-selling Kakadu C and Calm Cool + Corrected product lines with the introduction of next-generation products that are uniquely formulated with anti-aging ingredients to help reduce the appearance of wrinkles, fine lines, pores and discoloration.

  • Business Wire

    NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

    EMERYVILLE, Calif., May 05, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Advertisement
Advertisement